Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 622   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1983  |  Volume : 1  |  Issue : 3  |  Page : 106-110

Experiences With A Mucolytic Aerosol Preparation (MESNA) In Patients With Chronic Lung Diseases

Correspondence Address:
S. R Kamat

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

An open study of sodium 2 mercapto ethane-sulphonate (MESNA) daily over 10 days was done in 30 subjects with chronic lung diseases and sputum production. While 13 of them showed improvement, five deteriorated clinically. There was a reduction in sputum quantity in 11 subjects; sputum viscosity improved in all over two hours and in 26 subjects progressively. Moderately severe side effects were seen in six of 24 subjects in whom complaints like burning chest pain, increased dyspnoea, vomiting, headache, and giddiness were observed. There was significant decrease in FEV1 and FVC (but not PEF) which was maximal at 20-40 minutes and reversed later. MESNA aerosol merits further evaluation as a mucolytic in subjects with serious disease.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded141    
    Comments [Add]    

Recommend this journal